Oleksandr Napryeyenko

Learn More
OBJECTIVE To test the efficacy and safety of a once-daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. METHODS Multi-centre trial of 410(More)
  • 1